Ohara K, Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, et al. A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors. J Dermatol Sci. 2016;83:234–9.
Zattarin E, Nichetti F, Ligorio F, Mazzeo L, Lobefaro R, Fucà G et al. Case Report: prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary paget disease of the groin. Front Oncol 2022;12.
Caruso G, Barcellini A, Mazzeo R, Gallo R, Vitale MG, Passarelli A, et al. Vulvar Paget’s Disease: a systematic review of the MITO Rare Cancer Group. Cancers. 2023;15:1803.
Article CAS PubMed PubMed Central Google Scholar
St. Claire K, Hoover A, Ashack K, Khachemoune A. Extramammary Paget disease. Dermatol Online J 2019;25.
Chow A, Arteaga CL, Wang SE. When Tumor suppressor TGFβ meets the HER2 (ERBB2) Oncogene. J Mammary Gland Biol Neoplasia. 2011;16:81–8.
Article PubMed PubMed Central Google Scholar
Bianco MK, Vasef MA. HER-2 gene amplification in Paget Disease of the Nipple and Extramammary Site: a chromogenic in situ hybridization study. Diagn Mol Pathol. 2006;15:131.
Article CAS PubMed Google Scholar
Gatalica Z, Vranic S, Krušlin B, Poorman K, Stafford P, Kacerovska D, et al. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget’s disease. Cancer Med. 2020;9:1441–50.
Article CAS PubMed PubMed Central Google Scholar
Lu X, Zhang P, Zhu Y, Ye D. Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget’s disease. Oncol Lett. 2019;17:2677–86.
CAS PubMed PubMed Central Google Scholar
Takata M, Fujimoto A, Aoki H, Hatta N, Ooi A, Takehara K. erbB-2 overexpression but no activation of beta-catenin gene in extramammary Paget’s disease. J Invest Dermatol. 1999;113:258–62.
Article CAS PubMed Google Scholar
Tanskanen M, Jahkola T, Asko-Seljavaara S, Jalkanen J, Isola J. HER2 oncogene amplification in extramammary Paget’s disease. Histopathology. 2003;42:575–9.
Article CAS PubMed Google Scholar
Klos KS, Zhou X, Lee S, Zhang L, Yang W, Nagata Y, et al. Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of akt than either treatment alone. Cancer. 2003;98:1377–85.
Article CAS PubMed Google Scholar
Maeda T, Kitamura S, Nishihara H, Yanagi T. Extramammary Paget’s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies. Oncogene. 2020;39:5867–75.
Article CAS PubMed Google Scholar
Rassy E, Rached L, Pistilli B. Antibody drug conjugates targeting HER2: clinical development in metastatic breast cancer. Breast off J Eur Soc Mastology. 2022;66:217–26.
Hanawa F, Inozume T, Harada K, Kawamura T, Shibagaki N, Shimada S. A case of metastatic Extramammary Paget’s Disease responding to Trastuzumab plus Paclitaxel Combination Therapy. Case Rep Dermatol. 2011;3:223–7. h.
Article PubMed PubMed Central Google Scholar
Takahagi S, Noda H, Kamegashira A, Madokoro N, Hori I, Shindo H, et al. Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy. J Dermatol. 2009;36:457–61.
Article CAS PubMed Google Scholar
Sekiguchi N, Kubota S, Noguchi T, Fukushima T, Kobayashi T, Kanda S, et al. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget’s disease: four cases and a review. J Dermatol. 2020;47:1276–9.
Article CAS PubMed Google Scholar
Garcia M, Juhos S, Larsson M, Olason PI, Martin M, Eisfeldt J, et al. Sarek: a portable workflow for whole-genome sequencing analysis of germline and somatic variants. F1000Research. 2020;9:63.
Article PubMed PubMed Central Google Scholar
Simon A. FastQC: a quality control tool for high throughput sequence data. 2010.
Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25:1754–60.
Article CAS PubMed PubMed Central Google Scholar
van der Auwera G, O’Connor BD. Genomics in the cloud: using Docker, GATK, and WDL in Terra. First edition. Sebastopol, CA: O’Reilly Media; 2020.
Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using Phred I. Accuracy Assessment. Genome Res. 1998;8:175–85.
Article CAS PubMed Google Scholar
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.
Article CAS PubMed PubMed Central Google Scholar
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
Article PubMed PubMed Central Google Scholar
Pedersen BS, Quinlan AR. Mosdepth: quick coverage calculation for genomes and exomes. Bioinformatics. 2018;34:867–8.
Article CAS PubMed Google Scholar
Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinforma Oxf Engl. 2016;32:3047–8.
Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213–9.
Article CAS PubMed PubMed Central Google Scholar
McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. Ensembl Variant Effect Predictor Genome Biol. 2016;17:122.
Rozen SG. mSigAct 2023.
Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide Copy Number Detection and visualization from targeted DNA sequencing. PLOS Comput Biol. 2016;12:e1004873.
Article PubMed PubMed Central Google Scholar
Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199–205.
Article CAS PubMed PubMed Central Google Scholar
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.
Article CAS PubMed Google Scholar
Deshpande V, Luebeck J, Nguyen N-PD, Bakhtiari M, Turner KM, Schwab R, et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat Commun. 2019;10:392.
Article CAS PubMed PubMed Central Google Scholar
Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res. 2013;41:D970–6.
Article CAS PubMed Google Scholar
Jones RE, Austin C, Ackerman AB. Extramammary Paget’s disease. A critical reexamination. Am J Dermatopathol. 1979;1:101–32. https://doi.org/10.1097/00000372-197900120-00002.
Sundaramoorthy R, Murugan A, Nakoaka H, Inoue I. APOBEC: a molecular driver in cervical cancer pathogenesis. Cancer Lett. 2021;496:104–16.
Beleznay KM, Levesque MA, Gill S. Response to 5-fluorouracil in metastatic extramammary paget disease of the scrotum presenting as pancytopenia and back pain. Curr Oncol. 2009;16:81–3.
Article CAS PubMed PubMed Central Google Scholar
Little JT, Lehman VT, Morris JM, Lehman JS, Diehn FE. Spinal metastases of Extramammary Paget Disease with radiologic-pathologic correlation. J Radiol Case Rep. 2016;10:1–8.
Article PubMed PubMed Central Google Scholar
Richter CE, Hui P, Buza N, Silasi D-A, Azodi M, Santin AD, et al. HER-2/NEU overexpression in vulvar paget disease: the Yale experience. J Clin Pathol. 2010;63:544–7.
Article CAS PubMed Google Scholar
Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Tsutsumida A, Otsuka F, et al. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. Br J Dermatol. 2013;168:1259–66.
Article CAS PubMed Google Scholar
Angelico G, Santoro A, Inzani F, Straccia P, Arciuolo D, Mulè A, et al. Hormonal environment and HER2 status in Extra-mammary Paget’s Disease (eMPD): a systematic literature review and Meta-analysis with clinical considerations. Diagnostics. 2020;10:1040.
Article CAS PubMed PubMed Central Google Scholar
Yoneyama K, Kamada N, Kinoshita K, Kawashima T, Otani M, Endo H, et al. Androgen-deprivation regimen for multiple bone metastases of extramammary Paget disease.
留言 (0)